Feb 24, 2015
FDA Approves Farydak (panobinostat) for Multiple Myeloma
FDA Approves Farydak (panobinostat) for Multiple Myeloma
Panobinostat
syn……….http://newdrugapprovals.org/2014/01/23/panobinostat/
HDAC inhibitors, orphan drug
cas 404950-80-7
2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide (alternatively, N-hydroxy-3-(4-{[2-(2-methyl-1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-acrylamide)
Mol…
View On WordPress